Highlights of AIDS 2010
 |
|
*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.
Joseph J. Eron, Jr., MD, and Joel E. Gallant, MD, MPH, review the most clinically relevant data from this important conference.
Format: Microsoft PowerPoint (.ppt) |
File size: 1.93 MB
| Date posted: 8/5/2010
Slide topics include:
|
Browse Slides by Date - Descending
Implications of New Data on Complications Associated With ARV Regimens
 |
|
Pablo Tebas, MD, discusses implications of recent data suggesting that certain antiretroviral agents are associated with loss in bone mineral density and renal disease.
Format: Microsoft PowerPoint (.ppt) |
File size: 414 KB
| Date posted: 6/22/2010
Slide topics include:
|
Neurocognitive Dysfunction in HIV-Infected Patients
 |
|
Scott L. Letendre, MD, discusses possible causes and implications of neurocognitive disease in HIV-infected patients.
Format: Microsoft PowerPoint (.ppt) |
File size: 307 KB
| Date posted: 6/22/2010
Slide topics include:
|
Tenofovir-Associated Renal Dysfunction Improved but Not Fully Reversible Following Tenofovir Cessation in Majority of Patients
 |
|
Pre-tenofovir eGFR restored in only 42% of patients following tenofovir cessation; of these, only 2 patients no longer met the definition of renal impairment.
Format: Microsoft PowerPoint (.ppt) |
File size: 285 KB
| Date posted: 6/21/2010
Slide topics include:
|
Neurocognitive Function Improves With Initial Antiretroviral Therapy; Differences Between Regimens Noted
 |
|
Greatest improvement in neurocognitive function seen with all-NRTI regimen but greatest neuronal recovery seen with efavirenz-based regimen.
Format: Microsoft PowerPoint (.ppt) |
File size: 260 KB
| Date posted: 6/18/2010
Slide topics include:
|
Integrase Resistance Evolves Progressively During Failure of Integrase Inhibitor–Based Antiretroviral Therapy
 |
|
In an analysis of the SCOPE cohort, first virologic failure of an integrase inhibitor in treatment-experienced patients was associated with resistance mutations present in only a minority of patients but evolution and accumulation of resistance with longer time on failing integrase inhibitor regimen.
Format: Microsoft PowerPoint (.ppt) |
File size: 255 KB
| Date posted: 6/16/2010
Slide topics include:
|
Maraviroc Plus Zidovudine/Lamivudine Noninferior to Efavirenz Plus Zidovudine/Lamivudine as Initial ART in Patients With CCR5-Tropic HIV Only by Sensitive Phenotypic Tropism Assay
 |
|
In post hoc reanalysis of trial samples with highly sensitive phenotypic tropism assay, eliminating additional patients with CXCR4-using variants at baseline, maraviroc-containing regimen met noninferiority criteria; virologic responses similar to efavirenz-containing regimen at Week 48.
Format: Microsoft PowerPoint (.ppt) |
File size: 542 KB
| Date posted: 6/15/2010
Slide topics include:
|
SWITCHMRK: Switch to Raltegravir-Based Regimen Virologically Inferior to Continuing Lopinavir/Ritonavir-Based Regimen in Patients With Stable Viral Suppression
 |
|
Lopinavir/ritonavir-based regimen associated with higher proportion of patients with HIV-1 RNA < 50 copies/mL at Week 24 in a diverse study population that included some patients with extensive treatment experience.
Format: Microsoft PowerPoint (.ppt) |
File size: 644 KB
| Date posted: 6/15/2010
Slide topics include:
|
Acyclovir Reduces Risk of HIV Disease Progression in HIV/HSV-2–Coinfected Patients Not Receiving Antiretroviral Therapy
 |
|
But, suppression of HSV-2 by acyclovir did not reduce HIV-1 transmission.
Format: Microsoft PowerPoint (.ppt) |
File size: 353 KB
| Date posted: 6/15/2010
Slide topics include:
|
Fewer Deaths With Concurrent vs Sequential Antiretroviral and TB Therapy
 |
|
In the SAPIT trial, initiation of antiretroviral therapy during TB therapy associated with 56% reduction in risk of death vs initiating antiretroviral therapy following TB therapy completion
Format: Microsoft PowerPoint (.ppt) |
File size: 402 KB
| Date posted: 6/15/2010
Slide topics include:
|
Severe Vitamin D Deficiency in Swiss HIV-Infected Patients Not Associated With Antiretroviral Therapy
 |
|
Retrospective analysis shows substantially higher rates of vitamin D deficiency in HIV-infected Swiss patients in spring vs fall; multiple demographic and treatment factors significantly correlated with vitamin D levels in multivariate analysis.
Format: Microsoft PowerPoint (.ppt) |
File size: 406 KB
| Date posted: 6/15/2010
Slide topics include:
|
|
Use the following filters to quickly browse and download slides for your talks
Browse slides by:
All Slides by Date (351)
Program Type
Topic
Featured Content
Review important new publications with Expert Commentaries, Capsule Summaries, and Slidesets.
Capsule Summaries, Expert Highlights, Slides, and Expert Analysis from the meeting in Vienna.
Interactively assess your knowledge on the benefits and risks of earlier antiretroviral therapy.
|
|